Cellectis' strong cash position and pipeline updates boost confidence. See why CLLS stock could benefit from upcoming data in ...

Aptevo Therapeutics Inc. shares surged nearly 50% early Thursday on promising leukemia trial results, before paring gains in ...

Aptose Biosciences (APTO) announced the publication of preclinical data for Aptose’s lead hematology compound tuspetinib in Cancer Research ...

TuHURA Biosciences, Inc. (Nasdaq: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies ...

A Yale School of Medicine team has created lists of criteria to help clinicians determine when next-generation sequencing ...

Cincinnati Bengals wide receiver Ja'Marr Chase danced a touchdown celebration against the Dallas Cowboys in honor of Texas boy's Brixton Wood cancer battle.

Adverse events associated with ponatinib in CML and ALL were shown to have decreased significantly since its approval, ...

Novel triple-drug therapies have shown promise for various leukemia types, achieving high remission and response rates. Key ...

Novel triple-drug therapies are showing promise for patients with various kinds of leukemia, researchers reported at the ...

Moleculin Biotech shares are trading higher on Wednesday after the company announced the online publication of preclinical ...

Edward Viner, MD, retired acting chief of medicine at Pennsylvania Hospital in Philadelphia and chief of medicine emeritus at Cooper University Hospital in Camden, N.J., died of acute myeloid leukemia ...